title: Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.
abstract: Four segregation analyses concerning prostate cancer (CaP), three conducted in the United States and one in Northern Europe, have shown evidence for a dominant major gene but with different parameter estimates. A recent segregation analysis of Australian pedigrees has found a better fit of a two-locus model than single-locus models. This model included a dominantly inherited increased risk that was greater at younger ages and a recessively inherited or X-linked increased risk that was greater at older ages. Recent linkage analyses have led to the detection of at least 8 CaP predisposing genes, suggesting a complex inheritance and genetic heterogeneity. To assess the nature of familial aggregation of prostate cancer in France, segregation analysis was conducted in 691 families ascertained through 691 CaP patients, recruited from three French hospitals and unselected with respect to age at diagnosis, clinical stage or family history. This mode of family inclusion, without any particular selection of the probands, is unique, as probands from all previous analyses were selected according to various criteria. Segregation analysis was carried out using the logistic hazard regressive model, as incorporated in the REGRESS program, which can accommodate a major gene effect, residual familial dependences of any origin (genetic and/or environmental), and covariates, while including survival analysis concepts. Segregation analysis showed evidence for the segregation of an autosomal dominant gene (allele frequency of 0.03%) with an additional brother-brother dependence. The estimated cumulative risks of prostate cancer by age 85 years, among subjects with the at-risk genotype, were 86% in the fathers' generation and 99% in the probands' generation. This study supports the model of Mendelian transmission of a rare autosomal dominant gene with high penetrance, and demonstrates that additional genetic and/or common sibling environmental factors are involved to account for the familial clustering of CaP.
authors.affiliation: Centre de Recherche pour les Pathologies Prostatiques (CeRePP), UPRES EA3104 Université Paris VII, 45 rue des Saint-Pères 75006 Paris, France. Antoine.Valeri@univ-brest.fr
authors.forename: A
authors.initials: A
authors.lastname: Valeri
authors.forename: L
authors.initials: L
authors.lastname: Briollais
authors.forename: R
authors.initials: R
authors.lastname: Azzouzi
authors.forename: G
authors.initials: G
authors.lastname: Fournier
authors.forename: P
authors.initials: P
authors.lastname: Mangin
authors.forename: P
authors.initials: P
authors.lastname: Berthon
authors.forename: O
authors.initials: O
authors.lastname: Cussenot
authors.forename: F
authors.initials: F
authors.lastname: Demenais
mesh_terms: D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D041321:Chromosomes, Human, X; D005192:Family Health; D005787:Gene Frequency; D005799:Genes, Dominant; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D016013:Likelihood Functions; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D011471:Prostatic Neoplasms / Q000235:genetics*; D012307:Risk Factors